$OSIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSI PHARMACEUTICALS INC. Get notifications about new insider transactions in OSI PHARMACEUTICALS INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 06 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 30.02 | 400 | 12,008 | 72,705 | 73.1 K to 72.7 K (-0.55 %) |
Jun 06 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 30.00 | 9,468 | 284,040 | 73,105 | 82.6 K to 73.1 K (-11.47 %) |
Jun 06 2006 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 9.00 | 24,000 | 216,000 | 82,573 | 58.6 K to 82.6 K (+40.97 %) |
Mar 20 2006 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Grant | A | 0.00 | 248 | 0 | 19,323 | 19.1 K to 19.3 K (+1.30 %) |
Mar 20 2006 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Grant | A | 0.00 | 357 | 0 | 3,490 | 3.1 K to 3.5 K (+11.39 %) |
Mar 20 2006 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Grant | A | 0.00 | 248 | 0 | 3,823 | 3.6 K to 3.8 K (+6.94 %) |
Mar 20 2006 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Grant | A | 0.00 | 497 | 0 | 78,251 | 77.8 K to 78.3 K (+0.64 %) |
Mar 20 2006 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Grant | A | 0.00 | 298 | 0 | 18,682 | 18.4 K to 18.7 K (+1.62 %) |
Mar 20 2006 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Grant | A | 0.00 | 248 | 0 | 25,103 | 24.9 K to 25.1 K (+1.00 %) |
Mar 20 2006 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 1,193 | 0 | 15,886 | 14.7 K to 15.9 K (+8.12 %) |
Mar 20 2006 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Grant | A | 0.00 | 497 | 0 | 10,445 | 9.9 K to 10.4 K (+5.00 %) |
Mar 20 2006 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Grant | A | 0.00 | 497 | 0 | 2,467 | 2 K to 2.5 K (+25.23 %) |
Mar 14 2006 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Option Exercise | M | 9.25 | 7,665 | 70,901 | 0 | |
Mar 14 2006 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 33.01 | 55 | 1,816 | 18,384 | 18.4 K to 18.4 K (-0.30 %) |
Mar 14 2006 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 33.02 | 300 | 9,906 | 18,439 | 18.7 K to 18.4 K (-1.60 %) |
Mar 14 2006 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 33.03 | 600 | 19,818 | 18,739 | 19.3 K to 18.7 K (-3.10 %) |
Mar 14 2006 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 33.04 | 1,200 | 39,648 | 19,339 | 20.5 K to 19.3 K (-5.84 %) |
Mar 14 2006 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Buy | M | 9.25 | 7,665 | 70,901 | 20,539 | 12.9 K to 20.5 K (+59.54 %) |
Oct 31 2005 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 22.57 | 1,000 | 22,570 | 14,693 | 13.7 K to 14.7 K (+7.30 %) |
Dec 02 2005 | OSIP | OSI PHARMACEUTICAL ... | GUYER DAVID R | Exec. VP & CEO (OSI ... | Option Exercise | A | 23.83 | 100,000 | 2,383,000 | 100,000 | |
Nov 16 2005 | OSIP | OSI PHARMACEUTICAL ... | GUYER DAVID R | Exec. VP & CEO (OSI ... | Grant | A | 0.00 | 3,682 | 0 | 3,682 | 0 to 3.7 K |
Nov 16 2005 | OSIP | OSI PHARMACEUTICAL ... | GUYER DAVID R | Exec. VP & CEO (OSI ... | Grant | A | 0.00 | 144,628 | 0 | 144,628 | 0 to 144.6 K |
Oct 28 2005 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Grant | A | 22.50 | 3,000 | 67,500 | 7,550 | 4.6 K to 7.6 K (+65.93 %) |
Oct 27 2005 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Option Exercise | M | 9.25 | 4,000 | 37,000 | 7,665 | |
Oct 27 2005 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Buy | M | 9.25 | 4,000 | 37,000 | 12,874 | 8.9 K to 12.9 K (+45.08 %) |
Oct 26 2005 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Grant | A | 23.88 | 3,000 | 71,640 | 9,948 | 6.9 K to 9.9 K (+43.18 %) |
Oct 25 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Grant | A | 23.38 | 10,000 | 233,800 | 19,075 | 9.1 K to 19.1 K (+110.19 %) |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Grant | A | 21.99 | 6,500 | 142,935 | 7,433 | 933 to 7.4 K (+696.68 %) |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Grant | A | 21.99 | 2,300 | 50,577 | 3,133 | 833 to 3.1 K (+276.11 %) |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | M | 15.02 | 17,231 | 258,810 | 2,769 | |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | M | 5.38 | 50,000 | 268,750 | 0 | |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Buy | M | 15.02 | 17,231 | 258,810 | 77,754 | 60.5 K to 77.8 K (+28.47 %) |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Buy | M | 5.38 | 50,000 | 268,750 | 60,523 | 10.5 K to 60.5 K (+475.15 %) |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Grant | A | 21.99 | 3,000 | 65,970 | 10,523 | 7.5 K to 10.5 K (+39.88 %) |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Grant | A | 21.99 | 1,700 | 37,383 | 15,068 | 13.4 K to 15.1 K (+12.72 %) |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 9.00 | 20,000 | 180,000 | 24,000 | |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 9.00 | 20,000 | 180,000 | 58,573 | 38.6 K to 58.6 K (+51.85 %) |
Oct 24 2005 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Grant | A | 22.68 | 10,000 | 226,800 | 28,311 | 18.3 K to 28.3 K (+54.61 %) |
Oct 04 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 20.31 | 1,000 | 20,313 | 5,000 | |
Oct 04 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 29.17 | 500 | 14,585 | 9,075 | 9.6 K to 9.1 K (-5.22 %) |
Oct 04 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 29.02 | 1,000 | 29,021 | 9,575 | 10.6 K to 9.6 K (-9.46 %) |
Oct 04 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 20.31 | 1,000 | 20,313 | 10,575 | 9.6 K to 10.6 K (+10.44 %) |
Sep 06 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 20.31 | 1,000 | 20,313 | 6,000 | |
Sep 06 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 32.79 | 1,500 | 49,185 | 9,575 | 11.1 K to 9.6 K (-13.54 %) |
Sep 06 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 32.79 | 1,000 | 32,790 | 11,075 | 10.1 K to 11.1 K (+9.93 %) |
Aug 03 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | M | 16.81 | 1,500 | 25,220 | 21,500 | |
Aug 03 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 41.86 | 100 | 4,186 | 3,575 | 3.7 K to 3.6 K (-2.72 %) |
Aug 03 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 41.84 | 100 | 4,184 | 3,675 | 3.8 K to 3.7 K (-2.65 %) |
Aug 03 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 41.82 | 100 | 4,182 | 3,775 | 3.9 K to 3.8 K (-2.58 %) |
Aug 03 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 41.81 | 200 | 8,362 | 3,875 | 4.1 K to 3.9 K (-4.91 %) |
Aug 03 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 41.70 | 1,000 | 41,700 | 4,075 | 5.1 K to 4.1 K (-19.70 %) |
Aug 03 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Buy | M | 16.81 | 1,500 | 25,220 | 5,075 | 3.6 K to 5.1 K (+41.96 %) |
Aug 03 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 20.31 | 1,000 | 20,313 | 7,000 | |
Aug 03 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 41.81 | 1,500 | 62,715 | 10,075 | 11.6 K to 10.1 K (-12.96 %) |
Aug 03 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 20.31 | 1,000 | 20,313 | 11,575 | 10.6 K to 11.6 K (+9.46 %) |
Jul 06 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 20.31 | 1,000 | 20,313 | 8,000 | |
Jul 06 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 39.50 | 1,500 | 59,252 | 10,575 | 12.1 K to 10.6 K (-12.42 %) |
Jul 06 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 20.31 | 1,000 | 20,313 | 12,075 | 11.1 K to 12.1 K (+9.03 %) |
Jul 06 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | M | 16.81 | 1,500 | 25,220 | 23,000 | |
Jul 06 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 40.00 | 1,500 | 60,000 | 3,575 | 5.1 K to 3.6 K (-29.56 %) |
Jul 06 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Buy | M | 16.81 | 1,500 | 25,220 | 5,075 | 3.6 K to 5.1 K (+41.96 %) |
Jun 17 2005 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | A | 38.01 | 18,720 | 711,547 | 18,720 | |
Jun 17 2005 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Option Exercise | A | 38.01 | 21,850 | 830,519 | 21,850 | |
Jun 17 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | M | 16.81 | 1,500 | 25,220 | 24,500 | |
Jun 17 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 40.00 | 1,500 | 60,000 | 3,575 | 5.1 K to 3.6 K (-29.56 %) |
Jun 17 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Buy | M | 16.81 | 1,500 | 25,220 | 5,075 | 3.6 K to 5.1 K (+41.96 %) |
Jun 17 2005 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Option Exercise | A | 38.01 | 30,000 | 1,140,300 | 30,000 | |
Jun 17 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., On ... | Option Exercise | A | 38.01 | 36,430 | 1,384,704 | 36,430 | |
Jun 17 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | A | 38.01 | 46,960 | 1,784,950 | 46,960 | |
Jun 15 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 20.31 | 1,000 | 20,313 | 9,000 | |
Jun 15 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 38.30 | 300 | 11,490 | 11,075 | 11.4 K to 11.1 K (-2.64 %) |
Jun 15 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 38.28 | 1,200 | 45,936 | 11,375 | 12.6 K to 11.4 K (-9.54 %) |
Jun 15 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 20.31 | 1,000 | 20,313 | 12,575 | 11.6 K to 12.6 K (+8.64 %) |
May 06 2005 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Option Exercise | M | 21.55 | 2,500 | 53,875 | 834 | |
May 06 2005 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 47.46 | 442 | 20,977 | 3,280 | 3.7 K to 3.3 K (-11.88 %) |
May 06 2005 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 47.44 | 361 | 17,126 | 3,722 | 4.1 K to 3.7 K (-8.84 %) |
May 06 2005 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 47.42 | 100 | 4,742 | 4,083 | 4.2 K to 4.1 K (-2.39 %) |
May 06 2005 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 47.32 | 100 | 4,732 | 4,183 | 4.3 K to 4.2 K (-2.33 %) |
May 06 2005 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 47.28 | 1,381 | 65,294 | 4,283 | 5.7 K to 4.3 K (-24.38 %) |
May 06 2005 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 47.27 | 100 | 4,727 | 5,664 | 5.8 K to 5.7 K (-1.73 %) |
May 06 2005 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 47.24 | 16 | 756 | 5,764 | 5.8 K to 5.8 K (-0.28 %) |
May 06 2005 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Buy | M | 21.55 | 2,500 | 53,875 | 5,780 | 3.3 K to 5.8 K (+76.22 %) |
Jun 02 2005 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Option Exercise | A | 37.20 | 150,000 | 5,580,000 | 150,000 | |
Jun 02 2005 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Grant | A | 0.00 | 15,000 | 0 | 18,311 | 3.3 K to 18.3 K (+453.04 %) |
Jun 02 2005 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | D | 0.00 | 571 | 0 | 3,311 | 3.9 K to 3.3 K (-14.71 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | M | 16.81 | 1,500 | 25,220 | 26,000 | |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 47.47 | 900 | 42,723 | 3,575 | 4.5 K to 3.6 K (-20.11 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 47.44 | 100 | 4,744 | 4,475 | 4.6 K to 4.5 K (-2.19 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 47.43 | 500 | 23,715 | 4,575 | 5.1 K to 4.6 K (-9.85 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Buy | M | 16.81 | 1,500 | 25,220 | 5,075 | 3.6 K to 5.1 K (+41.96 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 21.55 | 1,250 | 26,938 | 8,955 | |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.50 | 300 | 14,250 | 4,899 | 5.2 K to 4.9 K (-5.77 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.49 | 200 | 9,498 | 5,199 | 5.4 K to 5.2 K (-3.70 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.42 | 200 | 9,484 | 5,399 | 5.6 K to 5.4 K (-3.57 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.41 | 100 | 4,741 | 5,599 | 5.7 K to 5.6 K (-1.75 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.39 | 300 | 14,217 | 5,699 | 6 K to 5.7 K (-5.00 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.38 | 150 | 7,107 | 5,999 | 6.1 K to 6 K (-2.44 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 21.55 | 1,250 | 26,938 | 6,149 | 4.9 K to 6.1 K (+25.52 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Option Exercise | A | 47.34 | 50,000 | 2,367,000 | 50,000 | |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Grant | A | 0.00 | 833 | 0 | 833 | 0 to 833 |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 21.55 | 1,000 | 21,550 | 10,205 | |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 50.00 | 1,000 | 50,000 | 4,899 | 5.9 K to 4.9 K (-16.95 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 21.55 | 1,000 | 21,550 | 5,899 | 4.9 K to 5.9 K (+20.41 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 21.55 | 798 | 17,197 | 1,584 | |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 50.00 | 798 | 39,900 | 4,544 | 5.3 K to 4.5 K (-14.94 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 21.55 | 798 | 17,197 | 5,342 | 4.5 K to 5.3 K (+17.56 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Option Exercise | M | 23.85 | 2,479 | 59,124 | 60,761 | |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 50.00 | 2,479 | 123,950 | 10,429 | 12.9 K to 10.4 K (-19.21 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Buy | M | 23.85 | 2,479 | 59,124 | 12,908 | 10.4 K to 12.9 K (+23.77 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 6.50 | 2,917 | 18,961 | 5,415 | |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 50.00 | 2,917 | 145,850 | 6,948 | 9.9 K to 6.9 K (-29.57 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 6.50 | 2,917 | 18,961 | 9,865 | 6.9 K to 9.9 K (+41.98 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 9.00 | 4,000 | 36,000 | 44,000 | |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 50.00 | 4,000 | 200,000 | 38,573 | 42.6 K to 38.6 K (-9.40 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 9.00 | 4,000 | 36,000 | 42,573 | 38.6 K to 42.6 K (+10.37 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Option Exercise | M | 21.55 | 467 | 10,064 | 1,332 | |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 50.00 | 467 | 23,350 | 10 | 477 to 10 (-97.90 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Buy | M | 21.55 | 467 | 10,064 | 477 | 10 to 477 (+4,670.00 %) |
Apr 18 2005 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Grant | A | 0.00 | 10 | 0 | 13,368 | 13.4 K to 13.4 K (+0.07 %) | |
Apr 18 2005 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Grant | A | 0.00 | 13,358 | 0 | 13,358 | 0 to 13.4 K | |
Apr 07 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 21.55 | 1,250 | 26,938 | 11,205 | |
Apr 07 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 45.00 | 1,250 | 56,250 | 4,899 | 6.1 K to 4.9 K (-20.33 %) |
Apr 07 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 21.55 | 1,250 | 26,938 | 6,149 | 4.9 K to 6.1 K (+25.52 %) |
Apr 04 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | M | 16.81 | 1,500 | 25,220 | 27,500 | |
Apr 04 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 41.40 | 1,500 | 62,100 | 3,575 | 5.1 K to 3.6 K (-29.56 %) |
Apr 04 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Buy | M | 16.81 | 1,500 | 25,220 | 5,075 | 3.6 K to 5.1 K (+41.96 %) |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | A | 45.60 | 7,500 | 342,000 | 7,500 | |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Grant | A | 45.60 | 685 | 31,236 | 11,575 | 10.9 K to 11.6 K (+6.29 %) |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | A | 45.60 | 15,000 | 684,000 | 15,000 | |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Grant | A | 45.60 | 685 | 31,236 | 3,575 | 2.9 K to 3.6 K (+23.70 %) |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Option Exercise | A | 45.60 | 7,500 | 342,000 | 7,500 | |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Grant | A | 45.60 | 1,371 | 62,518 | 1,970 | 599 to 2 K (+228.88 %) |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | A | 45.60 | 15,000 | 684,000 | 15,000 | |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Grant | A | 45.60 | 1,371 | 62,518 | 7,523 | 6.2 K to 7.5 K (+22.29 %) |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Option Exercise | A | 45.60 | 7,500 | 342,000 | 7,500 | |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Grant | A | 45.60 | 822 | 37,483 | 8,874 | 8.1 K to 8.9 K (+10.21 %) |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 45.60 | 15,000 | 684,000 | 15,000 | |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 45.60 | 3,289 | 149,978 | 13,693 | 10.4 K to 13.7 K (+31.61 %) |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | A | 45.60 | 10,000 | 456,000 | 10,000 | |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Grant | A | 45.60 | 1,371 | 62,518 | 6,948 | 5.6 K to 6.9 K (+24.58 %) |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Option Exercise | A | 45.60 | 7,500 | 342,000 | 7,500 | |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Grant | A | 45.60 | 987 | 45,007 | 24,855 | 23.9 K to 24.9 K (+4.14 %) |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Director | Option Exercise | A | 45.60 | 7,500 | 342,000 | 7,500 | |
Mar 18 2005 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Director | Grant | A | 45.60 | 685 | 31,236 | 3,882 | 3.2 K to 3.9 K (+21.43 %) |
Mar 10 2005 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Option Exercise | M | 48.30 | 40,000 | 1,932,000 | 40,000 | ||
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 21.55 | 2,250 | 48,488 | 12,455 | |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.70 | 28 | 1,532 | 4,899 | 4.9 K to 4.9 K (-0.57 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.50 | 16 | 872 | 4,927 | 4.9 K to 4.9 K (-0.32 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.31 | 16 | 869 | 4,943 | 5 K to 4.9 K (-0.32 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.30 | 31 | 1,683 | 4,959 | 5 K to 5 K (-0.62 %) |